[go: up one dir, main page]

IN2014MN01780A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01780A
IN2014MN01780A IN1780MUN2014A IN2014MN01780A IN 2014MN01780 A IN2014MN01780 A IN 2014MN01780A IN 1780MUN2014 A IN1780MUN2014 A IN 1780MUN2014A IN 2014MN01780 A IN2014MN01780 A IN 2014MN01780A
Authority
IN
India
Prior art keywords
abx
infection
prescribed
estimated
antibiotics
Prior art date
Application number
Other languages
English (en)
Inventor
Kfir Oved
Eran Eden
Ilan Ifergan
Original Assignee
Memed Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memed Diagnostics Ltd filed Critical Memed Diagnostics Ltd
Publication of IN2014MN01780A publication Critical patent/IN2014MN01780A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • G01N27/44726—Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44739—Collecting the separated zones, e.g. blotting to a membrane or punching of gel spots
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153 or CD154
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN1780MUN2014 2012-02-09 2013-02-08 IN2014MN01780A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596950P 2012-02-09 2012-02-09
US201261652631P 2012-05-29 2012-05-29
PCT/EP2013/052619 WO2013117746A1 (en) 2012-02-09 2013-02-08 Signatures and determinants for diagnosing infections and methods of use thereof

Publications (1)

Publication Number Publication Date
IN2014MN01780A true IN2014MN01780A (zh) 2015-07-03

Family

ID=47678877

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1780MUN2014 IN2014MN01780A (zh) 2012-02-09 2013-02-08

Country Status (13)

Country Link
US (4) US9726668B2 (zh)
EP (3) EP3367099B1 (zh)
JP (3) JP6169619B2 (zh)
CN (2) CN108802385B (zh)
AU (2) AU2013217935B2 (zh)
BR (1) BR112014019733B1 (zh)
CA (2) CA3133249C (zh)
ES (2) ES2679107T3 (zh)
HK (2) HK1204065A1 (zh)
IL (3) IL233998A (zh)
IN (1) IN2014MN01780A (zh)
WO (1) WO2013117746A1 (zh)
ZA (1) ZA201405993B (zh)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3059337B1 (en) 2009-01-15 2019-05-01 Adaptive Biotechnologies Corporation Adaptive immunity profiling and methods for generation of monoclonal antibodies
CA2796666C (en) 2010-04-21 2020-04-14 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
EP3367099B1 (en) 2012-02-09 2021-05-26 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
ES2662128T3 (es) 2012-03-05 2018-04-05 Adaptive Biotechnologies Corporation Determinación de cadenas de receptor inmunitario emparejadas a partir de la frecuencia de subunidades coincidentes
CN104520440B (zh) 2012-05-08 2017-10-03 适应生物技术公司 用于测量和校准多重pcr反应中的扩增偏倚的组合物和方法
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
EP3114240B1 (en) 2014-03-05 2019-07-24 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
CA2942405A1 (en) 2014-03-13 2015-09-17 Opgen, Inc. Methods of detecting multi-drug resistant organisms
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
EP3132059B1 (en) 2014-04-17 2020-01-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
WO2015184017A1 (en) 2014-05-27 2015-12-03 Opgen, Inc. Systems, apparatus, and methods for generating and analyzing resistome profiles
WO2015192050A1 (en) * 2014-06-13 2015-12-17 North Carolina State University Aptamers with binding affinity to norovirus
EP3180621B1 (en) 2014-08-14 2020-04-01 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CN107001455B (zh) 2014-11-19 2022-03-01 皇家飞利浦有限公司 利用hnl的诊断方法
WO2016092554A1 (en) 2014-12-11 2016-06-16 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
US11047008B2 (en) 2015-02-24 2021-06-29 Adaptive Biotechnologies Corporation Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
WO2016161273A1 (en) 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
EP3139171B1 (en) * 2015-09-02 2020-02-12 Labsystems Diagnostics Oy Novel methods and kits for detecting of urea cycle disorders using mass spectrometry
AU2016331663B2 (en) * 2015-09-30 2022-04-07 Immunexpress Pty Ltd Pathogen biomarkers and uses therefor
CN106918698B (zh) * 2015-12-25 2019-11-22 广州瑞博奥生物科技有限公司 一种检测人受体酪氨酸激酶的磷酸化抗体芯片试剂盒
CA3015043A1 (en) * 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
EP3423590A4 (en) * 2016-03-03 2020-02-26 Memed Diagnostics Ltd. DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS
CN106053831A (zh) * 2016-06-05 2016-10-26 潘时辉 一种用于自身免疫病检测的试剂盒
EP3464645A4 (en) * 2016-06-07 2020-05-06 The Board of Trustees of the Leland Stanford Junior University DIAGNOSTIC METHODS FOR BACTERIAL AND VIRAL INFECTIONS
EP3475702B3 (en) * 2016-06-23 2024-03-20 Memed Diagnostics Ltd. Measuring trail by lateral flow immunoassay
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
EP4141448A1 (en) 2016-07-10 2023-03-01 MeMed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
CN109844532B (zh) * 2016-08-10 2022-06-17 米密德诊断学有限公司 分析生物数据的系统和方法
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
JP6903494B2 (ja) * 2017-06-09 2021-07-14 シスメックス株式会社 感染症を識別するための粒子分析方法
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US20200241004A1 (en) * 2017-07-31 2020-07-30 University Health Network Biomarkers in ex vivo lung perfusion (evlp) perfusate
EP3707161A4 (en) * 2017-11-07 2021-10-27 Memed Diagnostics Ltd. ANTI-TRAIL ANTIBODIES AND METHOD OF USING THEM
US11896680B2 (en) * 2017-11-28 2024-02-13 Mie University Detection method
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
CN108039206B (zh) * 2017-12-21 2021-11-09 北京大学深圳研究生院 一种传染病的诊治方法及系统
AU2019212375A1 (en) * 2018-01-27 2020-07-30 Becton, Dickinson And Company Multiplex lateral flow assay for differentiating bacterial infections from viral infections
US11484273B2 (en) * 2018-03-06 2022-11-01 International Business Machines Corporation Determining functional age indices based upon sensor data
US20210230694A1 (en) * 2018-06-05 2021-07-29 University Of Rochester Nasal genes used to identify, characterize, and diagnose viral respiratory infections
CN108486246B (zh) * 2018-06-06 2020-06-09 青岛泱深生物医药有限公司 子痫前期的诊治标志物
JP2021533518A (ja) * 2018-08-02 2021-12-02 ブライト クリニカル リサーチ リミテッド 進行中の臨床研究試験の動的データモニタリングおよびリアルタイム最適化のためのシステム、方法、および処理
WO2020092443A1 (en) * 2018-10-29 2020-05-07 Thomas Jefferson University Compositions and methods for discriminating infectious from non-infectious cns disorders
WO2021057986A1 (zh) * 2019-09-27 2021-04-01 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备卵巢病变筛查试剂盒中的用途
CN110923333B (zh) * 2019-12-11 2020-09-29 湖北省农业科学院畜牧兽医研究所 山羊zbp1基因第一内含子内与产羔数关联的单倍型标记及其应用
CA3163458A1 (en) 2019-12-11 2021-06-17 Ichilov Tech Ltd. Non-invasive assay for differentiating between bacterial and viral infections
EP4097485A4 (en) * 2020-01-29 2024-05-15 MeMed Diagnostics Ltd. METHODS OF DIAGNOSIS AND CLASSIFICATION OF VIRAL INFECTIONS
KR20220151168A (ko) 2020-02-09 2022-11-14 엔엘씨 파르마 엘티디 Sars-cov-2에 대한 신속한 검출 테스트
WO2021204984A1 (en) 2020-04-09 2021-10-14 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of respiratory tract infections
EP4152000A4 (en) * 2020-06-30 2024-07-03 HORIBA, Ltd. Body fluid analysis device, method for determining body fluid sample, and computer program
CN111816245B (zh) * 2020-07-20 2022-09-09 成都博欣医学检验实验室有限公司 结合mNGS和临床知识库的病原微生物检测方法及系统
WO2022153323A1 (en) * 2021-01-18 2022-07-21 Memed Diagnostics Ltd. Markers for diagnosing infections
EP4308729A1 (en) * 2021-03-16 2024-01-24 Cepheid Methods for discriminating bacterial and viral infections in a human subject
CN113945712A (zh) * 2021-12-21 2022-01-18 山东中鸿特检生物科技有限公司 一种区别细菌、病毒感染的检测方法及检测试剂盒
CN114441506B (zh) * 2022-04-08 2022-06-21 港湾之星健康生物(深圳)有限公司 量子磁光传感器
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate

Family Cites Families (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1178414A (en) 1978-02-08 1984-11-27 Toyo Boseki Kabushiki Kaisha (Trading Under The Name Of Toyobo Co., Ltd.) Packaging material having excellent seal packaging property
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
US5018067A (en) 1987-01-12 1991-05-21 Iameter Incorporated Apparatus and method for improved estimation of health resource consumption through use of diagnostic and/or procedure grouping and severity of illness indicators
DE4322330A1 (de) 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
DE4227454C1 (de) 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
SE9401351D0 (sv) 1994-04-21 1994-04-21 Venge A method for diagnosis
US5910421A (en) 1995-12-21 1999-06-08 University Of Florida Rapid diagnostic method for distinguishing allergies and infections
US6077665A (en) 1996-05-07 2000-06-20 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in neonates
CA2315944A1 (en) 1997-12-24 1999-07-08 Diatech Pty. Ltd. Bifunctional molecules
AU762756B2 (en) 1998-05-18 2003-07-03 Apoptosis Technology, Inc. Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US6635461B1 (en) 1999-08-24 2003-10-21 Glycozym Aps UDP-N-acetylglucosamine: galactose-β1, 3-N-acetylgalactosamine-α-R/(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3
IL132687A0 (en) 1999-11-01 2001-03-19 Keren Mechkarim Ichilov Pnimit System and method for evaluating body fluid samples
US20020038227A1 (en) 2000-02-25 2002-03-28 Fey Christopher T. Method for centralized health data management
US7668661B2 (en) 2000-04-28 2010-02-23 Siemens Healthcare Diagnostics Inc. Liver disease-related methods and systems
WO2002007064A2 (en) 2000-07-17 2002-01-24 Labnetics, Inc. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US20020055176A1 (en) 2000-11-08 2002-05-09 Ray Robert A. Diagnostic assay system
KR100461715B1 (ko) 2001-03-27 2004-12-17 가부시끼가이샤 도시바 질환과 관련된 핵산의 검출 방법
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE10119804A1 (de) 2001-04-23 2002-10-24 Brahms Ag Entzündungsspezifische Peptide und deren Verwendungen
AU2002256895B2 (en) 2001-05-18 2008-09-18 Kirin Beer Kabushiki Kaisha Anti-TRAIL-R antibodies
FI115165B (fi) 2001-06-04 2005-03-15 Aboatech Ab Oy Menetelmä infektion laadun määrittämiseksi
DE10130985B4 (de) 2001-06-27 2004-03-18 B.R.A.H.M.S Ag Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
ATE278194T1 (de) 2001-12-07 2004-10-15 Brahms Ag Verwendungen der aldose-1-epimerase (mutarotase) für die diagnose von entzündungserkrankungen und sepsis
EP1317902B1 (en) 2001-12-10 2005-11-09 Kabushiki Gaisha K-and-S Biological data observation apparatus
US20040038201A1 (en) 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
US7468032B2 (en) 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
US20040122296A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management for triaging health-related data
EP1489416A4 (en) 2002-03-22 2005-09-28 Kyowa Medex Co Ltd METHOD FOR THE EVALUATION OF VIRUS INFECTION
US7485298B2 (en) * 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
KR20050040866A (ko) 2002-06-11 2005-05-03 아이다호 리서치 파운데이션 바이러스 감염의 검출을 위한 ⅰ형 인터페론-유도성 단백질
BR0315935A (pt) 2002-10-31 2005-09-20 Health Research Inc Teste de diagnóstico para o vìrus do nilo ocidental
US8563476B2 (en) 2002-11-15 2013-10-22 Morehouse School Of Medicine Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders
CA2528162A1 (en) 2003-06-04 2004-12-16 The Government Of The United States As Represented By The Secretary Of T He Department Of Health And Human Services, Centers For Disease Control Pni microarray and uses
US20050164238A1 (en) 2003-09-29 2005-07-28 Biosite, Inc. Methods and compositions for the diagnosis of sepsis
JP2005106694A (ja) 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
GB0401730D0 (en) 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
US8906630B2 (en) 2004-02-27 2014-12-09 The Trustees Of The University Of Pennsylvania Assays for detecting pathogenic respiratory bacteria
US7892539B2 (en) * 2004-03-24 2011-02-22 The Regents Of The University Of California Modulation of an innate immune response by altering TRIAL-R signaling
US8155993B2 (en) 2004-06-15 2012-04-10 Janssen Pharmaceutica, N.V. Apparatus and methods for assessing a pharmaceutical product
EP1787128A2 (en) 2004-07-09 2007-05-23 Amaox, Inc. Immune cell biosensors and methods of using same
WO2006023312A2 (en) 2004-08-20 2006-03-02 Carl Deirmengian Diagnostic assay for source of inflammation
EP1805500A4 (en) 2004-09-28 2008-05-07 Singulex Inc SYSTEM AND METHOD FOR THE SPECTROSCOPIC ANALYSIS OF INDIVIDUAL PARTICLES
US7572640B2 (en) 2004-09-28 2009-08-11 Singulex, Inc. Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
AU2005334466B2 (en) 2004-11-05 2011-05-26 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Diagnosis and prognosis of infectious disease clinical phenotypes and other physiologic states using host gene expression biomarkers in blood
WO2007018574A2 (en) 2004-11-10 2007-02-15 The United States Of America As Represented By The Secretary Of The Navy Diagnostic assay for rickettsia prowazekii disease by detection of responsive gene expression
CN101208602A (zh) 2005-04-15 2008-06-25 贝克顿迪金森公司 脓毒症的诊断
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
US20070015172A1 (en) 2005-06-01 2007-01-18 Z-Biomed, Inc. Expression profiles for microbial infection
UA78641C2 (en) 2005-08-29 2007-04-10 Open Joint Stock Company Conce A process for the preparation of carbamide-formaldehyde resin
DE102005050933A1 (de) 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
CN101374964B (zh) 2005-12-09 2013-07-17 贝勒研究院 外周血液白细胞转录模式的模块水平分析
GB0601959D0 (en) 2006-01-31 2006-03-15 King S College London Sepsis test
US20070184460A1 (en) 2006-02-09 2007-08-09 Wei-Mei Ching Diagnostic assay for Orientia tsutsugamushi by detection of responsive gene expression
CN101479389A (zh) 2006-04-26 2009-07-08 沃泰克斯药物股份有限公司 丙肝病毒感染生物标记
CA2695935A1 (en) 2006-08-11 2008-02-28 Baylor Research Institute Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
DE602007013620D1 (de) 2006-09-05 2011-05-12 Hvidovre Hospital Auf IP-10 basierende immunologische Überwachung
AU2012244350B2 (en) 2006-09-05 2013-08-15 Statens Serum Institut Ip-10 based immunological monitoring
US20100068147A1 (en) 2006-10-05 2010-03-18 Agency for Science , Technology and Research Dengue diagnosis and treatment
KR101532797B1 (ko) 2006-12-06 2015-07-01 메디뮨 엘엘씨 인터페론 알파 유도성 약력학적 마커
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
WO2008076077A1 (en) 2006-12-21 2008-06-26 Innogene Kalbiotech Pte Ltd Method of early diagnosis of epstein-barr virus-related cancer and respective reagents and kits
AU2008205622A1 (en) * 2007-01-11 2008-07-24 Duke University Method of monitoring HIV infection
WO2008095136A2 (en) 2007-01-31 2008-08-07 Henkin Robert I Methods for detection of biological substances
DE102007009751A1 (de) * 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
CA2679412A1 (en) 2007-02-28 2009-09-04 The Procter & Gamble Company Methods and targets for identifying compounds for regulating rhinovirus infection
MY150954A (en) 2007-06-01 2014-03-31 Council Scient Ind Res A novel method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
RU2352948C1 (ru) 2007-06-15 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "КРАСНОЯРСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" Способ прогноза исхода заболевания пациентов с ургентной хирургической патологией органов брюшной полости
IL184478A (en) 2007-07-08 2017-07-31 Hadasit Medical Res Services & Development Ltd Preparations, methods and kits for identifying carriers of mutations in genes 1brca and 2brca and for the early detection of cancers associated with mutations in these genes
DE102007035640A1 (de) 2007-07-27 2009-01-29 Lkh-Kunststoffwerk Gmbh & Co. Kg Tauchkolben
EP2301626B1 (en) * 2007-08-03 2013-01-16 B.R.A.H.M.S GmbH Antibiotic for use in local infection
EP2020603A1 (en) 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease
TW200920358A (en) 2007-08-13 2009-05-16 Lundbeck & Co As H Method of treating stress-mediated depression
WO2009025743A2 (en) * 2007-08-17 2009-02-26 University Of Massachusetts Medical School Use of trail compositions as antiviral agents
ATE463700T1 (de) 2007-09-24 2010-04-15 Bmdsys Production Gmbh Kryostat mit stabilisiertem aussengefäss
EP2071334A1 (en) 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
WO2009100907A1 (en) 2008-02-14 2009-08-20 Dianeering Diagnostics Engineering And Research Gmbh Means and methods for assessing the risk of patients presenting to emergency departments based on very low concentrations of troponin i or t or using a combination of markers
US8293880B2 (en) 2008-03-25 2012-10-23 University Of Southern California Prognostic panel for urinary bladder cancer
SG190570A1 (en) 2008-04-21 2013-06-28 Novartis Forschungsstiftung Antiviral therapy
US9910036B2 (en) 2008-05-20 2018-03-06 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
CA2721742A1 (en) 2008-05-23 2009-11-26 Pronota N.V. New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof
JP2011526152A (ja) 2008-06-25 2011-10-06 ベイラー リサーチ インスティテュート マイコバクテリウム・ツベルクローシス感染症の血液転写サイン
CN102257386B (zh) 2008-10-24 2014-12-31 B.R.A.H.M.S有限公司 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估
US20160041153A1 (en) 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers
CN102301002A (zh) 2008-11-12 2011-12-28 卡里斯生命科学卢森堡控股有限责任公司 使用外来体来确定表现型的方法和系统
TW201021778A (en) 2008-11-12 2010-06-16 Alcon Res Ltd Intraocular lens delivery device with a multi-part plunger tip
UA92843C2 (ru) 2009-05-21 2010-12-10 Институт Технической Теплофизики Национальной Академии Наук Украины Способ получения порошкообразного пищевого красителя из столовой свеклы
WO2010138618A1 (en) 2009-05-26 2010-12-02 Duke University Molecular predictors of fungal infection
CN102449486B (zh) 2009-06-05 2015-01-21 B.R.A.H.M.S有限公司 在患有呼吸困难的对象中检测细菌感染
EP2806272A1 (en) 2009-08-07 2014-11-26 Myriad RBM, Inc. Methods and devices for detecting kidney transplant rejection
JP5667353B2 (ja) 2009-09-25 2015-02-12 シスメックス株式会社 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム
JP5722587B2 (ja) 2009-10-13 2015-05-20 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス
AU2010306593B2 (en) 2009-10-15 2015-09-10 Crescendo Bioscience, Inc. Biomarkers and methods for measuring and monitoring inflammatory disease activity
CN102762743A (zh) 2009-12-09 2012-10-31 阿维埃尔公司 用于心血管疾病的诊断和分类的生物标记物检验
US20110312534A1 (en) 2010-03-05 2011-12-22 Erasmus University Medical Center Rotterdam Method for prediction of human iris color
EP2365456B1 (en) 2010-03-11 2016-07-20 CompuGroup Medical SE Data structure, method and system for predicting medical conditions
CA2796666C (en) 2010-04-21 2020-04-14 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
US20130071866A1 (en) 2010-05-31 2013-03-21 The University Of Tokushima Method for testing the severtiy of an illness
GB2482187A (en) 2010-07-23 2012-01-25 Univ Exeter Predicting response to surgery
US8877212B2 (en) 2011-02-07 2014-11-04 Trudeau Institute Use of an IL12 receptor-beta 1 splice variant to diagnose active tuberculosis
RU2476887C2 (ru) 2011-03-29 2013-02-27 Учреждение Российской академии медицинских наук Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения РАМН Способ прогнозирования развития осложнений у больных внебольничной пневмонией
EP2722343A4 (en) 2011-06-20 2014-12-17 Kyowa Hakko Kirin Co Ltd ANTI-ERBB3 ANTIBODIES
WO2013040062A2 (en) 2011-09-12 2013-03-21 Vanderbilt University Characterizing multiple sclerosis
JP5842107B2 (ja) 2011-10-19 2016-01-13 パナソニックＩｐマネジメント株式会社 循環動態測定装置
ES2656150T3 (es) 2011-11-14 2018-02-23 Universitätsklinikum Jena Diagnóstico de la sepsis y del síndrome de respuesta inflamatoria sistémica
WO2013119632A1 (en) 2012-02-07 2013-08-15 Ingber Michael Apparatus and methods for analyzing a medical condition
EP3367099B1 (en) 2012-02-09 2021-05-26 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN104159616B (zh) 2012-03-08 2017-10-31 托门医学股份公司 在牙科应用中用于诊断炎性组织的口香糖
EP2637023A1 (en) 2012-03-08 2013-09-11 B.R.A.H.M.S GmbH Prediction of outcome in patients with chronic obstructive pulmonary disease
US9375493B2 (en) 2012-03-30 2016-06-28 Visen Medical, Inc. Bacterial imaging agents and methods of using same
GB201211982D0 (en) 2012-07-05 2012-08-22 Isis Innovation Biomarker
US10036075B2 (en) 2012-07-10 2018-07-31 Nepean Blue Mountains Local Health District Risk stratification in influenza
FR2996003B1 (fr) 2012-09-25 2014-10-17 Commissariat Energie Atomique Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active
US20140127827A1 (en) 2012-11-05 2014-05-08 Gwangju Institute Of Science And Technology Method for detection of antigen using fluorescence resonance energy transfer immunoassay
SG11201504241QA (en) 2012-11-30 2015-06-29 Applied Proteomics Inc Method for evaluation of presence of or risk of colon tumors
RU2015135359A (ru) 2013-01-22 2017-03-02 Имикрок, С.Л. Быстрый способ детекции патогенов
US20150363559A1 (en) 2013-01-29 2015-12-17 Molecular Health Gmbh Systems and methods for clinical decision support
US10689701B2 (en) 2013-03-15 2020-06-23 Duke University Biomarkers for the molecular classification of bacterial infection
JP6185142B2 (ja) 2013-03-15 2017-08-23 ボストン サイエンティフィック ニューロモデュレイション コーポレイション 臨床応答データマッピング
EP3693738A1 (en) 2013-09-20 2020-08-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
WO2015048098A1 (en) 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
EP3180621B1 (en) 2014-08-14 2020-04-01 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
CN107001455B (zh) 2014-11-19 2022-03-01 皇家飞利浦有限公司 利用hnl的诊断方法
WO2016092554A1 (en) 2014-12-11 2016-06-16 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
KR20160072626A (ko) 2014-12-15 2016-06-23 전북대학교산학협력단 패혈증 인자 il-6 간이 진단 키트
US20180310854A1 (en) 2015-11-01 2018-11-01 Elminda Ltd. Method and system for estimating potential distribution on cortical surface
EP3423590A4 (en) 2016-03-03 2020-02-26 Memed Diagnostics Ltd. DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS
CA3015043A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
EP3475702B3 (en) 2016-06-23 2024-03-20 Memed Diagnostics Ltd. Measuring trail by lateral flow immunoassay
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
EP4141448A1 (en) 2016-07-10 2023-03-01 MeMed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
CN109716102B (zh) 2016-09-16 2023-05-16 芯片生物技术株式会社 微粒分注装置、微粒分析装置、反应检测装置、以及使用它们的方法
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US20220329345A1 (en) 2021-04-08 2022-10-13 Infinidome Ltd. Adjustable null steering in a stationary network

Also Published As

Publication number Publication date
JP6169619B2 (ja) 2017-07-26
CN108802385B (zh) 2022-02-08
US11175291B2 (en) 2021-11-16
HK1204065A1 (zh) 2015-11-06
IL233998A0 (en) 2014-09-30
US12188934B2 (en) 2025-01-07
JP2015510122A (ja) 2015-04-02
JP2020180975A (ja) 2020-11-05
CN104204803A (zh) 2014-12-10
IL284506A (en) 2021-08-31
BR112014019733B1 (pt) 2022-09-13
CA3133249C (en) 2023-07-25
IL284506B (en) 2022-06-01
US10502739B2 (en) 2019-12-10
AU2018202302A1 (en) 2018-04-26
EP2812700A1 (en) 2014-12-17
JP2017198696A (ja) 2017-11-02
ES2886979T3 (es) 2021-12-21
IL233998A (en) 2017-08-31
EP3367099B1 (en) 2021-05-26
EP3882633A1 (en) 2021-09-22
AU2013217935B2 (en) 2018-05-17
US9726668B2 (en) 2017-08-08
AU2013217935A1 (en) 2014-09-04
CN108802385A (zh) 2018-11-13
HK1253780A1 (zh) 2019-07-05
ES2679107T3 (es) 2018-08-22
CA2863819A1 (en) 2013-08-15
CA2863819C (en) 2021-11-23
US20220042994A1 (en) 2022-02-10
JP6725456B2 (ja) 2020-07-22
CA3133249A1 (en) 2013-08-15
CN104204803B (zh) 2018-08-07
EP3367099A1 (en) 2018-08-29
IL254095B (en) 2021-07-29
US20200088728A1 (en) 2020-03-19
WO2013117746A1 (en) 2013-08-15
EP2812700B1 (en) 2018-04-18
US20150017630A1 (en) 2015-01-15
IL254095A0 (en) 2017-10-31
US20170030909A1 (en) 2017-02-02
AU2018202302C1 (en) 2020-06-11
AU2018202302B2 (en) 2020-01-23
BR112014019733A2 (zh) 2017-08-22
ZA201405993B (en) 2015-11-25

Similar Documents

Publication Publication Date Title
IN2014MN01780A (zh)
MX2018004170A (es) Biomarcadores relacionados con enfermedades mediadas por interleucina-33 (il-33) y usos de los mismos.
EA201590655A8 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
MX376691B (es) Composición farmaceutica que comprende un antagonista de il-4r para tratar una infección cutánea.
MX2016016800A (es) Metodos para el tratamiento del sobrepeso o la obesidad.
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
MX376652B (es) Método para determinar la eficacia de una terapia con fármacos de direccionamiento a glipicano 3 (gpc3) contra cáncer.
EA201691155A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
BR112014024159A2 (pt) Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice.
MX2013000674A (es) Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer.
MX2015005798A (es) Terapia de combinacion.
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
WO2014015149A3 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
MX387627B (es) Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia
PH12015502500B1 (en) Bacteriophage therapy
EP4252742A3 (en) Fluticasone furoate in the treatment of copd
EA201590460A1 (ru) Способ и средство для лечения и профилактики заболеваний, вызываемых (+)рнк-содержащими вирусами
MA39447B1 (fr) Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
ECSP12012126A (es) Medicamento
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.
MA39448B1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
MX2019004200A (es) Terapia de combinacion.
EA202192767A1 (ru) Способ лечения опосредуемой нонсенс-мутацией мышечной дистрофии дюшенна у педиатрических пациентов
MX2014013491A (es) Metodos para mantener, tratar o mejorar la funcion cognitiva.